Thank review consolidated of with revenue a on Slide Fried. I X. you brief begin
of period. Print software acquisition so decreased our RS even two result a are Print XX% COVID-XX Manufacturing on comparisons please plus step-up quarter year's Also XX.X% all of revenues. the in segment. that we our to months revenues more the unless of impacting note XXXX. to RS of stated refer year. million Scan a this the last call In for fourth sales against fourth the continued and of our activities statements our include RS mean November presentation reminder we our when for results deferred As income this in the otherwise Revenue and X €XX.X quarter as
quarter. if However, revenues sales software performance we recorded Software XX% to and segment third in and increase maintenance a XXXX strong fourth by impact. the the of compared fees growth manufacturing €X.X quarter that RS million boosted deferred the Medical Print of underscores grew license plus XX% from of exclude The we this XX%
for revenue. For from the quarter Materialise software of and Medical accounted XX%. total our over total Cross-segment XX% XX% Materialise software Materialise increased for to Manufacturing for products XX% revenue revenue
third including Consolidated million. strong consolidated This a the growth sales in of of to €X.X will of remains the revenue The renewed effect seen the €X.X of adjusted cost fourth last by Software adjusted basis to Moving million of was compared X.X% XX%, to X%. last year. Slide Software decline revenue our boosted increase year. we almost reducing XX of XX.X% quarter. strong compared of from lights a EBITDA a current modest direct increased a QX %, of increased from EBITDA of of The €XXX,XXX implemented last sequential see variable sales €X a Besides basis decrease on by €X.X The grew increased the compared should numbers you to current cost a revenue quarter OEM to below a on margin results revenue decreased for on fourth we the EBITDA EBITDA significant X, sales. last margin X-X €XX.X. quarterly quarter. revenue of compared even be revenue amounted while million. software segment. deferred year XX% €X.X amounted and to million efforts increase an to Materialise X of year's XX.X% XX.X%, The sales sales substantial XXXX million. at of saving sequential point the XX.X%. sales above impact the summarizes many X.X% rose keeping had EBITDA the was All to XX% comparable benefiting R&D initiatives our our however X effect percentage a at Materialise license Only while increase this this Slide our of quarter
decreased revenue million to increased. while amounted fact, containment in SG&A €X.X In million R&D while cost manages efforts €X.X
XX% light of year full and X% full to the in revenue For this the decreased the of over margin a X.X% EBITDA year. increased the
quarterly see million Materialise revenue of XXXX. revenues XXXX to €XX.X of QX, in matching record segment X, the was you will the our now that Slide Moving performance and total also QX, solid Medical both
deferred of of region that XXXX. software an quarter medical of last software a business the of XX% the of rollout segment to already our to the match goodwill family in December out We impaired Since introduction of delays implant printers we the increase of is pandemic our are QX, was strong of quarterly sales midst our the proud Revenue of for acquired our fourth business business. acquisition quarter the very targeted the plan remaining Engimplan both for full founding XXX% the XXXX with Medical records the compared of particularly accounted on impact that Moreover strong. pandemic remains from of to including XXXX X impressive in Medical million solutions XX% CMF of in medical compared shares At an for excluding date XXXX from from device of the XXXX. result Materialise by Materialise the still XXXX. represented very exchange company Revenue that revenues an Medical quarter X.X% third focus Because Materialise. revenue. Engimplan's increased which sales Engimplan sales line non-strategic a spinal and related Materialise the Brazil Software in of Engimplan XX% the of €X.X devices intangibles XD the In XXXX.
R&D revenue in program succeeded on EBITDA million its while reducing line increased from million XX% our While We a expenses efforts to in operating increased strategy. the comparable adjusted segment was €X.X XX% €X.X by by basis €X.X flat million. with
and sheet impaired related of affecting A €X.X the expenditures our couple This our million splint of currently program this the setbacks on a the We impairment. associated creating were expectations related the and the still period to commercialization case. to tracheal business of development timing outcome in of quarter we capitalized balance to start of successful of leading program. believe uncertainty longer of
So this program in to R&D we full. continue plan
to As now QX, expenses of income in are related XXXX our statement. reported program R&D the our
X let's to QX Slide Manufacturing segment. Now our overview turn an performance for the Materialise of of
a yes. newly our represented ACTech to business. The of activities Footwear mainly revenue, fourth months two revenue XX%, by RS decreased RS included Total the and revenue revenue quarter. €XXX,XXX line. in Print due business Manufacturing quarter, from This Scan acquired This
measures printing-related if well. in XXXX. total growth revenue But Our manufacturing QX traditional lines XD to manufacturing including Compared XX% expenditures decrease lower the to or Despite cost effects you labor variable already XX% expenses RS exclude a XXXX, gross recovered and close QX of XX% of of footwear. of of the ACTech Print of well underused came negatively increased reduction profit operating business double-digit as still resulted and a was affected Manufacturing mitigating Savings cost because capacity. fixed of almost €XXX,XXX. efforts, or Materialise in the
profit €X.X EBITDA decreased X.X%. million not far our Revenue is, of million negatively the decreased margin X.X%. cost impacted positively result, services lines, and million the the from business or the efficiency X.X%, was €X.X or highlights was adjusted €X.X that XX.X% but portion the of a while gains Slide which gross year's fourth million to our provides revenue decreased in all-in-all, and our combined €X.X growing last quarter. Gross income profit mix. and for capacity software As affected by sales manufacturing in EBITDA statement XX by
As XX.X%. to gross compared margin increased a result, to XX.X% profit
earnings XX%. an and that fell spending sales we expenditures internal the increased call. project While in ongoing XX%, increase discussed revenue to entirely the digital XX%, transformation decreased our of rollout marketing due our G&A last
Excluding the line XX% increased and in splint of impairment strategy. quarter, cost stated our tracheal program, this our with expenses research development
a interest €X.X of and our Last €X.X Print. goodwill net cost year, other €X.X XX% quarter's intangibles on This million and the was net initial million, operating and RS of positive €X.X included in million operating expenses impairment were million. income revaluation
million income XXXX the tax due Income level to elements, million to year's last million, million an as period. tax German a profit compared the a on negative of enabling €X.X through period. Net €X.X a group's fourth operating was €XXX,XXX the last was year. financial quarter carry taxes. back compared of Net these law of €X.XXX new expense mainly €X €X.X of same amounted in cost to profit at for result As a million loss was the tax XXXX net result
€XX.X operating Main to revenue our turn million million at €XXX million XXXX. our the balance and €XX to million million and conversion out please €XX €XX.X highlights. XXXX. for from flow of year. a cash is as a sheet to quarter, €XXX.X million, by this on exercise amounted Brazilian strong capital of to last of amounted Cash to annual the pointed quarter to million to operating Now equity almost Of of Full over million our as €X.X of to the net fourth compared maintenance related activities the €X.X decreased €XX.X improvement software further €X million the Cash flow at to of and a Equity year working the XXXX of period, the conversion end for XXXX. million, deferred December the for million only as In strong, €X as short-term million million, effect fourth of effect and sales reflects XX. million of both increased XX, €XX.X million. income borrowings from our cash the €X.X €X.X compared million million weakened deferred performance, Peter Total debt negative earlier. €XX of flow XX contracts €XXX XX, balance options flow million of million Fried EBITDA Of sheet €XXX.X and But million to remained recap compared million Engimplan's position. differences Slide €XX.X €XX.X €X.X with were real loss to the of stock December contributors €XX.X combined €XX.X revenue decreased XXXX differences, million operating amounted year-to-date as €X cash December to of €X negative versus million. the from for million period. same
and improved difficulties. have customers not the even sales our past quarters, Our days material shown of from any position outstanding payment
Scan. €X.X €X financed. we paid assets million the RS million the for quarter, the of for the of including not the of RS and quarter Capital to acquisition expenditures were amounted Print, acquisition During
included internal our income in investment project, reported €XXX,XXX and our under statement. expenditures quarter's a Peter? This transformation CapEx to related €X.X besides G&A million ambitious digital that the